Royal Bank Of Canada Issues Pessimistic Forecast for IDEX (NYSE:IEX) Stock Price

Key Points

• RBC lowered its IDEX price target slightly from $285 to $283 while maintaining an “outperform” rating, implying approximately 18% upside from the $239.67 trading price.
• IDEX delivered stronger-than-expected quarterly results, with revenue rising 8.3% year over year to $951.7 million and EPS of $2.33 topping the $2.24 consensus estimate.
• Analyst sentiment remains broadly positive, with nine Buy ratings and three Holds producing a “Moderate Buy” consensus and an average price target of $263.64, though the stock’s roughly 34-times earnings valuation and recent insider sale present cautionary factors.

IDEX (NYSE:IEX - Get Free Report) had its target price reduced by analysts at Royal Bank Of Canada from $285.00 to $283.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an "outperform" rating on the industrial products company's stock. Royal Bank Of Canada's target price suggests a potential upside of 18.08% from the company's current price.

Several other equities research analysts have also issued reports on IEX. KeyCorp raised shares of IDEX to a "hold" rating in a research report on Monday, October 12th. Oppenheimer raised their target price on shares of IDEX from $275.00 to $280.00 and gave the company an "outperform" rating in a research note on Thursday. Argus lifted their target price on shares of IDEX from $250.00 to $260.00 and gave the company a "buy" rating in a report on Thursday, August 6th. DA Davidson set a $245.00 price target on shares of IDEX in a research report on Thursday. Finally, Mizuho upgraded IDEX from a "neutral" rating to an "outperform" rating and increased their price target for the company from $210.00 to $280.00 in a report on Tuesday, August 11th. Nine equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, IDEX presently has an average rating of "Moderate Buy" and an average target price of $263.64.

IDEX Trading Up 0.5%

Shares of IDEX stock traded up $1.13 during trading hours on Thursday, reaching $239.67. The stock had a trading volume of 1,294,262 shares, compared to its average volume of 736,589. The firm has a 50 day simple moving average of $230.00 and a two-hundred day simple moving average of $215.45. The firm has a market capitalization of $17.67 billion, a price-to-earnings ratio of 34.49, a P/E/G ratio of 2.60 and a beta of 0.97. The company has a current ratio of 3.05, a quick ratio of 2.15 and a debt-to-equity ratio of 0.46. IDEX has a 1 year low of $160.60 and a 1 year high of $243.80.

IDEX (NYSE:IEX - Get Free Report) last issued its earnings results on Wednesday, October 28th. The industrial products company reported $2.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.09. The business had revenue of $951.70 million during the quarter, compared to analysts' expectations of $934.36 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%. The company's revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.03 EPS. As a group, equities research analysts anticipate that IDEX will post 8.83 earnings per share for the current year.

Insider Activity

In other news, CAO Lisa Anderson sold 385 shares of IDEX stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total transaction of $91,857.15. Following the sale, the chief accounting officer owned 4,327 shares in the company, valued at $1,032,378.93. This trade represents a 8.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On IDEX

Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in IDEX in the 2nd quarter valued at about $1,301,393,000. Primecap Management Co. CA purchased a new stake in shares of IDEX during the second quarter worth about $748,951,000. Amundi lifted its stake in shares of IDEX by 19.6% in the second quarter. Amundi now owns 1,458,979 shares of the industrial products company's stock worth $331,017,000 after acquiring an additional 239,579 shares in the last quarter. Bank of America Corp DE lifted its stake in shares of IDEX by 215.0% in the first quarter. Bank of America Corp DE now owns 1,094,101 shares of the industrial products company's stock worth $207,387,000 after acquiring an additional 746,732 shares in the last quarter. Finally, Alyeska Investment Group L.P. boosted its holdings in IDEX by 101.4% in the second quarter. Alyeska Investment Group L.P. now owns 1,042,703 shares of the industrial products company's stock valued at $236,641,000 after purchasing an additional 525,048 shares during the last quarter. 97.96% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: IDEX reported record third-quarter sales of $951.7 million, up 8.3% year over year, while adjusted earnings of $2.33 per share exceeded the $2.24 consensus estimate. Net income rose to $144.1 million from $127.8 million, and operating cash flow increased to $239.5 million. IDEX Corporation Reports Earnings Results
• Positive Sentiment: Management raised or reaffirmed an upbeat 2026 outlook, projecting 6.5%–6.8% organic sales growth and adjusted diluted EPS of $8.91–$8.96. Orders rose 13% year over year to $991.2 million, indicating solid demand momentum. IDEX 2026 Outlook
• Positive Sentiment: Health & Science Technologies was particularly strong, with sales up 14% to $433.5 million. Fluid & Metering Technologies and Fire & Safety/Diversified Products also posted year-over-year growth, while IDEX returned $129 million to shareholders through dividends and repurchases. IDEX Record Third-Quarter Sales
• Positive Sentiment: Stifel Nicolaus raised its price target from $267 to $273 and assigned a “buy” rating, implying further upside from the recent trading level. Stifel Nicolaus IDEX Rating
• Neutral Sentiment: RBC slightly reduced its price target from $285 to $283 but maintained an “outperform” rating, signaling continued confidence despite a modest valuation adjustment. RBC IDEX Price Target
• Negative Sentiment: At roughly 34 times earnings, IDEX remains relatively richly valued, which could limit additional gains or increase sensitivity to any slowdown. Recent insider activity cited in the coverage consisted of sales and no purchases, a modest cautionary signal. IDEX Valuation Analysis

About IDEX

IDEX Corporation is an industrial manufacturing company headquartered in Lake Forest, Illinois. The company designs and produces engineered products and technologies used to move, control, measure and apply fluids, as well as equipment used in fire and safety applications.

IDEX operates through businesses serving fluid and metering technologies, health and science technologies, and fire and safety markets. Its products include pumps, valves, flow meters, compressors, dispensing equipment, precision fluidics components and systems, fire pumps, rescue tools and other specialized equipment.

The company serves a broad range of industries, including healthcare, life sciences, water and wastewater, chemical processing, energy, food and beverage, agriculture, industrial manufacturing and municipal fire protection.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.